Haemophilus influenzae type b conjugate vaccine

S. A. Plotkin, R. S. Daum, G. S. Giebink, C. B. Hall, M. Lepow, E. K. Marcuse, G. H. McCracken, C. F. Phillips, G. B. Scott, H. T. Wright, G. Peter, A. R. Hinman, P. Parkman, R. Gold, J. G. Easton

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

On Dec 22, 1987, the first conjugate vaccine was licensed by the FDA for the prevention of infections due to Haemophilus influenzae type b. This vaccine is a conjugate of H influenzae type b capsular polysaccharide and diphtheria toxoid and is officially designated as Haemophilus b conjugate vaccine (diphtheria toxoid-conjugate). The purpose of this statement is to provide background information, perspective, and recommendations for the use of this product.

Original languageEnglish (US)
Pages (from-to)908-911
Number of pages4
JournalPediatrics
Volume81
Issue number6
StatePublished - Jan 1 1988
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Haemophilus influenzae type b conjugate vaccine'. Together they form a unique fingerprint.

  • Cite this

    Plotkin, S. A., Daum, R. S., Giebink, G. S., Hall, C. B., Lepow, M., Marcuse, E. K., McCracken, G. H., Phillips, C. F., Scott, G. B., Wright, H. T., Peter, G., Hinman, A. R., Parkman, P., Gold, R., & Easton, J. G. (1988). Haemophilus influenzae type b conjugate vaccine. Pediatrics, 81(6), 908-911.